Laxatives Market Research Report - Forecast till 2027

Laxatives Market Research Report: Information by Drug Type (Hyperosmotic and Bulk-Forming), Route of Administration (Oral and Rectal), Indication (Chronic Constipation and Irritable Bowel Syndrome), End User (Hospitals & Clinics, Research Institutes and others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/2055-HCR | February 2021 | Region: Global | 85 Pages         

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

 

6. GLOBAL LAXATIVES MARKET, BY DRUG TYPE

6.1. Overview

6.2. Hyperosmotic

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Bulk-Forming

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Stool Softeners

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5. Lubricants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6. Stimulants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7. Other

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION

7.1. Overview

7.2. Oral

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Rectal

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL LAXATIVES MARKET, BY INDICATION

8.1. Overview

8.2. Chronic Constipation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Irritable Bowel Syndrome

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

GLOBAL LAXATIVES MARKET, BY END USER

9.1. Overview

9.2. Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3. Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10. GLOBAL LAXATIVES MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Laxatives Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of the Number of Developments in the Global Laxatives Market

11.7. Key developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Mergers and Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix & Market Ratio

11.8.1. Sales & Operating Income 2020

11.8.2. Major Players R&D Expenditure 2020

11.9. Major Players Capital Market Ratio

12. COMPANY PROFILES

12.1. Bayer AG

12.1.1. Company Overview

12.1.2. Product Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Boehringer Ingelheim Pharmaceuticals Inc.

12.2.1. Company Overview

12.2.2. Product Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Eskag Pharma Pvt. Ltd.

12.3.1. Company Overview

12.3.2. Product Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. GlaxoSmithKline Plc

12.4.1. Company Overview

12.4.2. Product Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Procter & Gamble Company

12.5.1. Company Overview

12.5.2. Product Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Purdue Pharma L.P.

12.6.1. Company Overview

12.6.2. Product Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Mallinckrodt Pharmaceuticals

12.7.1. Company Overview

12.7.2. Product Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Abbott Laboratories

12.8.1. Company Overview

12.8.2. Product Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Braintree

12.9.1. Company Overview

12.9.2. Product Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Sucampo Pharmaceuticals

12.10.1. Company Overview

12.10.2. Product Overview

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Others

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL LAXATIVES MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL LAXATIVES MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 7 GLOBAL LAXATIVES MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 10 NORTH AMERICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 11 NORTH AMERICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 12 US: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 13 US: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 14 US: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 15 US: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 CANADA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 17 CANADA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 18 CANADA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 19 CANADA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 LATIN AMERICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 21 LATIN AMERICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 22 LATIN AMERICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 23 LATIN AMERICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 24 EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 25 EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 26 EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 27 EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 31 WESTERN EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL LAXATIVES MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL LAXATIVES MARKET

FIGURE 4 GLOBAL LAXATIVES MARKET SHARE, BY DRUG TYPE, 2020 (%)

FIGURE 5 GLOBAL LAXATIVES MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2020 (%)

FIGURE 6 GLOBAL LAXATIVES MARKET SHARE, BY INDICATION, 2020 (%)

FIGURE 7 GLOBAL LAXATIVES MARKET SHARE, BY END USER, 2020 (%)

FIGURE 8 GLOBAL LAXATIVES MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: LAXATIVES MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: LAXATIVES MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL LAXATIVES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 BAYER AG.: KEY FINANCIALS

FIGURE 16 BAYER AG: SEGMENTAL REVENUE

FIGURE 17 BAYER AG: REGIONAL REVENUE

FIGURE 18 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: KEY FINANCIALS

FIGURE 19 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: SEGMENTAL REVENUE

FIGURE 20 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: REGIONAL REVENUE

FIGURE 21 ESKAG PHARMA PVT. LTD.: KEY FINANCIALS

FIGURE 22 ESKAG PHARMA PVT. LTD.: SEGMENTAL REVENUE

FIGURE 23 ESKAG PHARMA PVT. LTD.: REGIONAL REVENUE

FIGURE 24 GLAXOSMITHKLINE PLC: KEY FINANCIALS

FIGURE 25 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

FIGURE 26 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

FIGURE 27 PROCTER & GAMBLE COMPANY: KEY FINANCIALS

FIGURE 28 PROCTER & GAMBLE COMPANY: SEGMENTAL REVENUE

FIGURE 29 PROCTER & GAMBLE COMPANY: REGIONAL REVENUE

FIGURE 30 PURDUE PHARMA L.P.: KEY FINANCIALS

FIGURE 31 PURDUE PHARMA L.P.: SEGMENTAL REVENUE

FIGURE 32 PURDUE PHARMA L.P.: REGIONAL REVENUE

FIGURE 33 MALLINCKRODT PHARMACEUTICALS: KEY FINANCIALS

FIGURE 34 MALLINCKRODT PHARMACEUTICALS: SEGMENTAL REVENUE

FIGURE 35 MALLINCKRODT PHARMACEUTICALS: REGIONAL REVENUE

FIGURE 36 ABBOTT LABORATORIES: KEY FINANCIALS

FIGURE 37 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 38 ABBOTT LABORATORIES: REGIONAL REVENUE

FIGURE 39 BRAINTREE: KEY FINANCIALS

FIGURE 40 BRAINTREE: SEGMENTAL REVENUE

FIGURE 41 BRAINTREE: REGIONAL REVENUE

FIGURE 42 SUCAMPO PHARMACEUTICALS: KEY FINANCIALS

FIGURE 43 SUCAMPO PHARMACEUTICALS: SEGMENTAL REVENUE

FIGURE 44 SUCAMPO PHARMACEUTICALS: REGIONAL REVENUE

Laxatives Market

Laxatives Market is expected to register a CAGR of 6 % and was valued at USD 10,834 Million.

Segmentation

By Drug Type Hyperosmotic And Bulk Forming
Route of Administration Oral And Rectal
Indication Chronic Constipation And Irritable Bowel Syndrome
End User Hospitals & Clinics Research Institutes And Others

Key Players

  • Bayer AG (Germany)
  • Boehringer Ingelheim Pharmaceuticals Inc. (Germany)
  • Eskag Pharma Pvt. Ltd. (India)
  • GlaxoSmithKline Plc (UK)
  • Procter & Gamble Company (US)
  • Purdue Pharma L.P.(US)
  • Mallinckrodt Pharmaceuticals (UK)
  • Abbott Laboratories (US)
  • Braintree (US)
  • AstraZeneca plc (UK)
  • Sucampo Pharmaceuticals (US)

Drivers

  • Increasing sedentary lifestyle.
  • The Higher prevalence of constipation in the geriatric population
Speak to Analyst Request a Free Sample

Laxatives Market Overview


Laxatives can be recognized as supplements that can be useful and helpful in loosening the stools and further, help in easy and increased bowel movements. If any individual is suffering from constipation, laxatives can act as great healers. Also, if an individual is having issues because of the hard and dry stools that cause pain, laxatives help in their treatment too. The general dose of laxatives is thrice a week. This is preferred as a form of medication because this comes into the picture when other ways to treat and cure constipation do not help in curing the ailment.


Occasional constipation can often be cured without the help of laxatives. These are usually available in the form of OTC drugs and can be taken without the doctor’s prescription. These have present in the market for quite some time now. However, the efficiency is still a matter of doubt owing to the lack of evidence. In children, the use of laxatives should be done only after consulting with a doctor. The laxative nature is likely dependent on the degeneration capacity of nerves that are a part of the intestines. In some circumstances, the dulling nature will also result in stimulating the peristalsis movement. 


Owing to its demand and solution for both children and adult-related stool problems, the laxatives market size is expected to grow during the forecast period ending in 2022. As per the market trends and demand for laxatives, the projected laxatives market valuation stands at USD 5,574.6 million. The laxatives market is expecting a 5.9% CAGR growth by the end of the forecast period in 2022.


 COVID 19 Analysis of Laxatives Market 


Since the arrival of the pandemic, the demand for better healthcare services and medication is on the rise. Though the other markets and industry vertices are adjusting to the new norms that have been accelerated the healthcare department has witnessed a surge in demand. However, the demand for laxatives particularly is stagnant and is showing progress at a very minimal scale. Also, with the development of more techniques and treatment, alongside the risks related to eating medicine without a prescription, the demand for laxatives is still.


Not going on medication is one of the major concerns and to curb the same, the government is putting forward regulations, schemes, and offers that will benefit a larger audience. Also, the prominent laxatives market players are focusing on product launches and are also opening their willingness for mergers and acquisitions that is likely to help in portfolio development and product enhancement.


Laxatives Market Dynamics


Drivers


There is a rise in the prevalence of constipation amongst various people suffering from the same, across the globe. There is an exceptional increase in the adoption of laxatives, especially in countries that have a low income. The key laxatives market players are taking various steps that will help in creating information and growing awareness amongst the general population. The market is in dire need of awareness related to gastrointestinal diseases and problems. These are collaborating to help the market with the needed drivers on the way of its global laxatives market growth by the end of the forecast period in 2022.


Restraints


The consumption of laxatives has the potential to cause other health concerns like flatulence and bloating sickness feeling, and dehydration along with constantly occurring abdominal cramps. Constipation in itself is troublesome and hence, tends to overshadow these issues. But, looking at the larger picture, these factors are restraints on the path of global growth for the laxatives market. Another restraint for the market is the use of laxatives as a treatment for reducing and cutting down the weight of obese people.


Technology Analysis


The problem of constipation is emerging as one of the major and most common problems. The main reason behind this is the sedentary lifestyle of people. This includes factors disturbed sleep cycle, bad eating habits, irregularity in mealtimes, and lack of exercise. These result in gastric imbalance and the result of the same is constipation. Hence, the demand for the consumption of laxatives is increasing in both adults and children. However, the prescription and its necessity may vary in these cases.


Regional Market Summary


Global Laxatives Market Share (%), by Region, 2018


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, and Annual Reports


Study Objectives



  • To consider the opinions and suggestions of the key industry experts and market traders and have an analysis of the market dynamics like drivers and restraints for the growth

  • To study the impact of the pandemic on the market operations and the eligibility of the laxatives market segments to serve the needs in various geographies across the globe and further note their impact on the future market valuation by the end of 2022

  • To analyze and draw a competitive market graph amongst the prominent players of the market and also understand their steps and key market strategies for global dominance that will help the laxatives market grow as per the prediction by the end of the ongoing forecast period in 2022


Laxatives Market Segment Overview


The rise of lifestyle changes amongst people is increasing the demand for the global laxatives market. However, to enhance their reach and opt for providing and developing services on a large scale, the market has been segmented based on the following:


Drug type


Based on the drug type for the global laxatives market, the drugs that are used are hyperosmotic, stimulants, lubricants, bulk-forming, alongside stool softeners. 


Administration


The administration is either oral or rectal.


Indication


The indication for health issues for laxatives include chronic constipation and irritable bowel syndrome


End-user


The laxatives market, end-users include hospitals, clinics, along with the research and technology-based institutes


Region


Owing to the above-stated segments, the regions include the North American countries, European nations, the APAC region, along with the Middle East and Africa amongst others


Laxatives Market Regional Analysis


The population of countries like the USA and Canada is moving towards a sedentary lifestyle and hence, the demand for laxatives is increasing in these regions. In the historic year of 2017, the North American region expected a dominant growth in global competition. However, if the developing regions are eyeing towards giving tough global competition, the dire need is for the development of ways through which laxative drugs will be accepted by a large audience. These regions have emerged and seen a larger preference and demand for home and traditional remedies that need to be curbed and challenged if a reliable need and demand for laxatives has to be generated.


Competitive Landscape of Laxatives Market 


To get a better understanding of the factors that influence the final market valuation, it is mandatory to have an idea of the revenue cycles of the key laxatives market players. The players functioning to expand the laxatives market revenue are as follows:



  • Boehringer Ingelheim Pharmaceuticals, Inc.

  • Sucampo Pharmaceuticals (US)

  • Procter and Gamble (US)

  • Procter & Gamble Company

  • Bayer AG, GlaxoSmithKline Plc

  • Braintree (US)

  • Braintree Laboratories, Inc.

  • Purdue Pharma L.P.


Recent Developments



  • Lifestyle disorders are more prominent in the population belonging to countries like India, New Zealand, alongside Australia. Hence, these are emerging as large markets for laxatives owing to which, the key market players are investing in innovative steps that will enhance the research and development departments of these countries.

  • The efforts of the European market players are showing positive results and hence Europe alongside Latin America are emerging as major geographies that have a promising future for the expansion of the global market.

  • The forecast period also holds a promising future owing to the lifestyle changes resulting in the rise of gastrointestinal problems of the population belonging to the Middle East and African population. The players in these regions are investing in mass production and the availability of laxatives to meet the demand during the ongoing forecast period that ends in 2022.

  • The North American players are investing in the development of various dosages to suit the need of a larger audience. The market players are on the way to develop tablets, powders, and capsules and also are developing gels and liquids to help the consumers consume them as per their preference.


Intended Audience



  • Retail companies and pharmaceuticals

  • Hospital pharmacies

  • Chemist shops and other healthcare institutions

  • Online pharmacies and medical stores

  • Drug outlets

  • Children having constipation issues can use this on a doctor’s prescription

  • Adults


Report Overview


The global laxatives market research report aims to understand the impact of the pandemic on the market operations and further discuss the dynamics like growth, opportunities, and risks available. The market report discusses the futuristic scope by helping to understand the revenue potential of the various market segments functioning in various locations across the globe. The laxatives market report also considers the opinions of the experts and key market players to predict the expected CAGR rate of growth and market valuation. Also, the report helps to have an idea about the leading market players and regions by discussing the recent developments undertaken by them during the forecast period that ends in 2022.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   5.9% (2019-2022)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Drug Type, Route of Administration, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bayer AG (Germany), Boehringer Ingelheim Pharmaceuticals Inc. (Germany), Eskag Pharma Pvt. Ltd. (India), GlaxoSmithKline Plc (UK), Procter & Gamble Company (US), Purdue Pharma L.P.(US), Mallinckrodt Pharmaceuticals (UK) , Abbott Laboratories (US) , Braintree (US), AstraZeneca plc (UK), Sucampo Pharmaceuticals (US)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing sedentary lifestyle.
  • The Higher prevalence of constipation in the geriatric population


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Global Laxatives Market is projected to grow at a 5% CAGR between 2017-2022.

    North America is predicted to dominate the Laxatives Market.

    Different end use industries of Laxatives Market include research institutes and hospitals & clinics.

    Lack of exercise and increasing sedentary lifestyle are adding market growth.

    Presence of alternatives and some side effects may limit market growth.